Allergy Diagnostics Market - 2024-2031

September 2024 | 45 pages | ID: AA3C1E6829D4EN
DataM Intelligence

US$ 3,400.00 US$ 4,350.00 -22 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Allergy Diagnostics Marketis is growing with a CAGR of 10.30% during the forecast period 2026-2035.

The Allergy Diagnostics Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A Allergy Diagnostics Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By Product Type
  • Assay Kits*
  • Consumables
By Allergen Type
  • Inhaled Allergens*
  • Food Allergens
  • Drug Allergens
By End User
  • Hospital-based laboratories*
  • Diagnostic Laboratories
  • Academic Research Laboratories
Regional Analysis for Allergy Diagnostics Market:
  • North America (U.S., Canada, Mexico)
  • Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
  • Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
  • South America (Colombia, Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
This Report Covers:
  • Go-to-market Strategy.
  • Neutral perspective on the market performance.
  • Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
  • Customized regional/country reports as per request and country level analysis.
  • Potential & niche segments and regions exhibiting promising growth covered.
  • Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Research Process:

Both primary and secondary data sources have been used in the global Allergy Diagnostics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. MARKET DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Market Snippet By Product Type
3.2. Market snippet By Allergen Type
3.3. Market Snippet By End User
3.4. Market Snippet by Region

4. MARKET DYNAMICS

4.1. Market Impacting Factors
  4.1.1. Drivers
    4.1.1.1. The rising environmental pollution levels
    4.1.1.2. Increasing Burden of Infectious Diseases?
  4.1.2. Restraints:
    4.1.2.1. Premium costs associated with allergy diagnostic instruments
  4.1.3. Opportunity
  4.1.4. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis

6. COVID-19 ANALYSIS

6.1. Analysis of Covid-19 on the Market
  6.1.1. Before COVID-19 Market Scenario
  6.1.2. Present COVID-19 Market Scenario
  6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion

7. BY PRODUCT TYPE

7.1. Introduction
  7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
  7.1.2. Market Attractiveness Index, By Product Type Segment
7.2. Assay Kits*
  7.2.1. Introduction
  7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Consumables

8. BY ALLERGEN TYPE

8.1. Introduction
  8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Allergen Type
  8.1.2. Market Attractiveness Index, By Allergen Type
8.2. Inhaled Allergens*
  8.2.1. Introduction
  8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Food Allergens
8.4. Drug Allergens

9. BY END USER

9.1. Introduction
  9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  9.1.2. Market Attractiveness Index, By End User Segment
9.2. Hospital-based laboratories*
  9.2.1. Introduction
  9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Diagnostic Laboratories
9.4. Academic Research Laboratories

10. BY REGION

10.1. Introduction
  10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
  10.1.2. Market Attractiveness Index, By Region
10.2. North America
  10.2.1. Introduction
  10.2.2. Key Region-Specific Dynamics
  10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Allergen Type
  10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    10.2.6.1. The U.S.
    10.2.6.2. Canada
    10.2.6.3. Mexico
10.3. Europe
  10.3.1. Introduction
  10.3.2. Key Region-Specific Dynamics
  10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Allergen Type
  10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    10.3.6.1. Germany
    10.3.6.2. U.K.
    10.3.6.3. France
    10.3.6.4. Italy
    10.3.6.5. Spain
    10.3.6.6. Rest of Europe
10.4. South America
  10.4.1. Introduction
  10.4.2. Key Region-Specific Dynamics
  10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Allergen Type
  10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    10.4.6.1. Brazil
    10.4.6.2. Argentina
    10.4.6.3. Rest of South America
10.5. Asia Pacific
  10.5.1. Introduction
  10.5.2. Key Region-Specific Dynamics
  10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Allergen Type
  10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    10.5.6.1. China
    10.5.6.2. India
    10.5.6.3. Japan
    10.5.6.4. Australia
    10.5.6.5. Rest of Asia Pacific
10.6. Middle East and Africa
  10.6.1. Introduction
  10.6.2. Key Region-Specific Dynamics
  10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Allergen Type
  10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. COMPETITIVE LANDSCAPE

11.1. Key Developments and Strategies
11.2. Company Share Analysis
11.3. Product Benchmarking

12. COMPANY PROFILES

12.1. BioMerieux SA*
  12.1.1. Company Overview
  12.1.2. Product Portfolio and Description
  12.1.3. Key Highlights
  12.1.4. Financial Overview
12.2. Danaher Corporation
12.3. Showa Denko Materials Co., Ltd. (Hitachi Chemical Diagnostics)
12.4. HOB Biotech Group Corp. Ltd
12.5. HYCOR Biomedical
12.6. Lincoln Diagnostics Inc.
12.7. Omega Diagnostics Group Plc
12.8. Siemens Healthineers AG
12.9. Stallergenes Greer Ltd
12.10. Thermo Fischer Scientific Inc(*LIST NOT EXHAUSTIVE)

13. DATAM INTELLIGENCE

13.1. Appendix
13.2. About Us and Services
13.3. Contact Us


More Publications